Holdings (Monthly)
Guide ↗
State Street(R) SPDR(R) S&P(R) Pharmaceuticals ETF
· Spdr Series Trust| # | Name | Ticker | Since | Shares | Value | % Port | Cat |
|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors | 857492706 | Mar 2026 | 24,400,789 | $24.4M | 7.93% | STIV |
| 2 | Enliven Therapeutics Inc | 29337E102 | Mar 2026 | 192,297 | $7.5M | 2.45% | EC |
| 3 | Corcept Therapeutics Inc | 218352102 | Mar 2026 | 174,971 | $7.1M | 2.29% | EC |
| 4 | Terns Pharmaceuticals Inc | 880881107 | Mar 2026 | 126,197 | $6.7M | 2.16% | EC |
| 5 | Perrigo Co PLC | 000000000 | Mar 2026 | 601,785 | $6.5M | 2.10% | EC |
| 6 | Axsome Therapeutics Inc | 05464T104 | Mar 2026 | 37,013 | $6.3M | 2.03% | EC |
| 7 | Innoviva Inc | 45781M101 | Mar 2026 | 263,314 | $6.1M | 1.99% | EC |
| 8 | Merck & Co Inc | 58933Y105 | Mar 2026 | 50,800 | $6.1M | 1.98% | EC |
| 9 | Pfizer Inc | 717081103 | Mar 2026 | 216,247 | $6.1M | 1.97% | EC |
| 10 | Royalty Pharma PLC | 000000000 | Mar 2026 | 126,441 | $6.1M | 1.97% | EC |
| 11 | Elanco Animal Health Inc | 28414H103 | Mar 2026 | 251,749 | $6.0M | 1.96% | EC |
| 12 | Jazz Pharmaceuticals PLC | 000000000 | Mar 2026 | 31,838 | $6.0M | 1.96% | EC |
| 13 | Esperion Therapeutics Inc | 29664W105 | Mar 2026 | 2,194,800 | $6.0M | 1.95% | EC |
| 14 | Edgewise Therapeutics Inc | 28036F105 | Mar 2026 | 190,497 | $6.0M | 1.95% | EC |
| 15 | MBX Biosciences Inc | 55287L101 | Mar 2026 | 200,744 | $6.0M | 1.95% | EC |
| 16 | Definium Therapeutics Inc | 24477V105 | Mar 2026 | 316,882 | $6.0M | 1.95% | EC |
| 17 | Bristol-Myers Squibb Co | 110122108 | Mar 2026 | 98,425 | $6.0M | 1.94% | EC |
| 18 | ANI Pharmaceuticals Inc | 00182C103 | Mar 2026 | 77,382 | $6.0M | 1.93% | EC |
| 19 | Johnson & Johnson | 478160104 | Mar 2026 | 24,295 | $5.9M | 1.93% | EC |
| 20 | Tarsus Pharmaceuticals Inc | 87650L103 | Mar 2026 | 84,481 | $5.9M | 1.92% | EC |
| 21 | Trevi Therapeutics Inc | 89532M101 | Mar 2026 | 494,432 | $5.9M | 1.92% | EC |
| 22 | Pacira BioSciences Inc | 695127100 | Mar 2026 | 258,586 | $5.8M | 1.90% | EC |
| 23 | Zoetis Inc | 98978V103 | Mar 2026 | 49,282 | $5.8M | 1.89% | EC |
| 24 | Crinetics Pharmaceuticals Inc | 22663K107 | Mar 2026 | 159,642 | $5.8M | 1.88% | EC |
| 25 | Nektar Therapeutics | 640268306 | Mar 2026 | 80,506 | $5.8M | 1.88% | EC |
| 26 | Liquidia Corp | 53635D202 | Mar 2026 | 153,099 | $5.8M | 1.88% | EC |
| 27 | Amneal Pharmaceuticals Inc | 03168L105 | Mar 2026 | 464,477 | $5.8M | 1.88% | EC |
| 28 | Harmony Biosciences Holdings Inc | 413197104 | Mar 2026 | 205,054 | $5.7M | 1.87% | EC |
| 29 | Supernus Pharmaceuticals Inc | 868459108 | Mar 2026 | 110,926 | $5.7M | 1.86% | EC |
| 30 | Viatris Inc | 92556V106 | Mar 2026 | 422,585 | $5.7M | 1.85% | EC |
| 31 | Xeris Biopharma Holdings Inc | 98422E103 | Mar 2026 | 975,649 | $5.7M | 1.84% | EC |
| 32 | Harrow Inc | 415858109 | Mar 2026 | 159,813 | $5.6M | 1.83% | EC |
| 33 | Organon & Co | 68622V106 | Mar 2026 | 922,423 | $5.5M | 1.79% | EC |
| 34 | Nuvation Bio Inc | 67080N101 | Mar 2026 | 1,286,168 | $5.5M | 1.79% | EC |
| 35 | Phibro Animal Health Corp | 71742Q106 | Mar 2026 | 99,625 | $5.5M | 1.79% | EC |
| 36 | Amylyx Pharmaceuticals Inc | 03237H101 | Mar 2026 | 395,413 | $5.5M | 1.79% | EC |
| 37 | Indivior Pharmaceuticals Inc | 45579U109 | Mar 2026 | 179,821 | $5.5M | 1.78% | EC |
| 38 | Collegium Pharmaceutical Inc | 19459J104 | Mar 2026 | 165,736 | $5.5M | 1.78% | EC |
| 39 | Eli Lilly & Co | 532457108 | Mar 2026 | 5,904 | $5.4M | 1.76% | EC |
| 40 | Prestige Consumer Healthcare Inc | 74112D101 | Mar 2026 | 91,089 | $5.4M | 1.75% | EC |
| 41 | Ligand Pharmaceuticals Inc | 53220K504 | Mar 2026 | 26,684 | $5.3M | 1.73% | EC |
| 42 | Ocular Therapeutix Inc | 67576A100 | Mar 2026 | 621,423 | $5.3M | 1.71% | EC |
| 43 | Omeros Corp | 682143102 | Mar 2026 | 494,846 | $5.2M | 1.70% | EC |
| 44 | EyePoint Inc | 30233G209 | Mar 2026 | 395,677 | $5.1M | 1.66% | EC |
| 45 | Alumis Inc | 022307102 | Mar 2026 | 224,127 | $4.9M | 1.60% | EC |
| 46 | Amphastar Pharmaceuticals Inc | 03209R103 | Mar 2026 | 227,681 | $4.5M | 1.45% | EC |
| 47 | Phathom Pharmaceuticals Inc | 71722W107 | Mar 2026 | 398,901 | $4.4M | 1.44% | EC |
| 48 | Theravance Biopharma Inc | 000000000 | Mar 2026 | 268,815 | $4.4M | 1.42% | EC |
| 49 | Rapport Therapeutics Inc | 75383L102 | Mar 2026 | 134,504 | $4.2M | 1.37% | EC |
| 50 | Arvinas Inc | 04335A105 | Mar 2026 | 362,073 | $3.8M | 1.25% | EC |
| 51 | CorMedix Inc | 21900C308 | Mar 2026 | 554,307 | $3.8M | 1.22% | EC |
| 52 | BioAge Labs Inc | 09077V100 | Mar 2026 | 210,974 | $3.7M | 1.20% | EC |
| 53 | Maze Therapeutics Inc | 578784100 | Mar 2026 | 117,041 | $3.5M | 1.13% | EC |
| 54 | Septerna Inc | 81734D104 | Mar 2026 | 128,633 | $3.1M | 1.00% | EC |
| 55 | WaVe Life Sciences Ltd | 000000000 | Mar 2026 | 419,283 | $3.0M | 0.99% | EC |
| 56 | Zevra Therapeutics Inc | 488445206 | Mar 2026 | 324,871 | $3.0M | 0.98% | EC |
| 57 | Fulcrum Therapeutics Inc | 359616109 | Mar 2026 | 367,717 | $2.8M | 0.92% | EC |
| 58 | Aquestive Therapeutics Inc | 03843E104 | Mar 2026 | 600,305 | $2.5M | 0.81% | EC |
| 59 | LB Pharmaceuticals Inc | 50180M108 | Mar 2026 | 89,202 | $2.2M | 0.71% | EC |
| 60 | Alto Neuroscience Inc | 02157Q109 | Mar 2026 | 73,288 | $1.6M | 0.54% | EC |
| 61 | State Street Global Advisors | 857492706 | Mar 2026 | 257,196 | $257K | 0.08% | STIV |
| 62 | State Street Global Advisors | 857492706 | Mar 2026 | 5,482 | $5K | 0.00% | STIV |